ISC Pre-Conference Symposium 2013
Tuesday, Feb. 5, 2013
Hawaii Convention Center
1801 Kalakaua Ave.
Check back here in September for programming information for the ISC Pre-Conference Symposium 2013.
Symposium Description
Check back here in September for programming information for the ISC Pre-Conference Symposium 2013.
Symposium Description
The Pre-Conference Symposium of the International Stroke Conference is designed to provide up-to-date information for healthcare professionals caring for patients with, or at risk for stroke. Each year, this one-day symposium highlights scientific advances in cerebrovascular disease while emphasizing their application in the real world. The symposium informs the audience about issues along the full continuum of stroke care and covers varied topics of interest to healthcare providers working in the emergency department, hospitalist settings, primary care, general neurology, rehabilitation, pharmacies, and other stroke care arenas.
Please note that there is a separate registration fee to attend the ISC Pre-Conference Symposium.
CME Information
Continuing Medical Education Accreditation - Physicians
Please note that there is a separate registration fee to attend the ISC Pre-Conference Symposium.
CME Information
Continuing Medical Education Accreditation - Physicians
The American Heart Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Continuing Medical Education Accreditation – Physician Assistants
AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
All persons who develop and/or control educational content in CME/CE activities sponsored by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME/CE-certified content of this activity. In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations. Such disclosures will be made in writing in course presentation materials.
